The Pistoia Alliance Conference in April 2011 included a series of 10-minute "lightning talks" from vendors about what they think pharma will look like in 2020. This presentation was delivered by Richard Resnick of GenomeQuest (and yes, this 41 slide talk was over in just 8 minutes!)
5. Why not? p-values diagnostics translational medicine 1000 genomes clinical personalized medicine inheritance patterns pathology my genome ms cure population study biological significance genomic medicine cancer genomics pharmacogenomics HIPPA compliance
6. “ I want to outsource the elements of our research pipeline that are pre-competitive .” - VP Research, unnamed Top 10 pharma “ We’ve decided to build our own internal pipeline for managing sequence data.” - Director of Bioinformatics, same company
7. “ We need to be innovative straight across the company .” - CEO, Unnamed Top 5 pharma “ We don’t have a genomics strategy .” - Director of Bioinformatics, same company “ Collaborations to rescue drugs using genomics are a key strategy for us this year.” - VP Translational Medicine, same company
8. “ We want to keep our intellectual property safe and secure.” - Chief Counsel, Top 10 pharma “ Over 50% of our company compares proprietary sequences directly against the open, unsecured NCBI website.” - Director of Bioinformatics, same company